AGL logo

AGILON HEALTH INC

AGLNYSE
πŸ† #1636 by market capEarnings Nov 2US Equity
$86.39β–Ό $9.28 (βˆ’10.74%)
Live
1hβ€”
24hβ–Ό 10.7%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$1.44B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+0.3%
Slowing
πŸ“ŠGross Margin
3.8%
Thin
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
0.3x
Cheap
Otter Score
64
Fair
No chart data available for AGL.

Trading Snapshot

Day Range
$85.06 – $88.00
52-Week Range
$7.48 – $133.04
Volume
$6.65B
Avg Volume
$6.20B
Shares Outstanding
16.7M
Next Earnings
Sep 25, 2026

Fundamentals Snapshot

Annual Revenue
$5.93B
Last Q Revenue
$1.49B
P/E Ratio
β€”
P/S Ratio
0.3x
EPS (TTM)
$-14.06
Dividend Yield
β€”

Why Investors Own AGL

  • βœ“High-growth profile β€” revenue up +25.5% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 67% gross margin and 25% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$5.93Bβ–² +29.8% YoY
Gross Margin (TTM)
67.3%β–² +3.5% YoY
Operating Income (TTM)
$1.68Bβ–² +29.8% YoY
Free Cash Flow (TTM)
$1.50Bβ–² +29.8% YoY

About AGILON HEALTH INC

Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States. As of December 31, 2021, the company served an approximate total of 238,000 senior clients. This figure included 186,300 individuals enrolled in Medicare Advantage plans and 51,700 recipients of Medicare fee-for-service benefits. The enterprise, which commenced operations in 2016, was initially incorporated as Agilon Health Topco, Inc. before rebranding to its current name, agilon health, inc., in March 2021. Its corporate headquarters are situated in Austin, Texas.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
64/100

Analyst Price Target

β“˜
Average Target
$108.42
β–² +25.5% Upside
High Target$133.27
Low Target$94.52
Based on 26 analysts

Latest News & Updates